Cernostics
A life science company developing new molecular diagnostic tests to treat cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$30m (Public information from Oct 2021)
Pittsburgh Pennsylvania (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $350k | Angel | |
$150k | Grant | ||
N/A | $394k | Debt | |
$2.6m | Series A | ||
N/A | $240k | Grant | |
N/A | N/A | Seed | |
N/A | N/A | Seed | |
N/A | Debt | ||
$1.4m | Seed | ||
$1.4m | Series B | ||
$2.0m | Early VC | ||
$5.0m | Early VC | ||
$2.5m | Series A | ||
N/A | $6.0m | Early VC | |
$30.0m Valuation: $30.0m | Acquisition | ||
Total Funding | $21.6m |
Recent News about Cernostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.